Wednesday, October 24, 2018

The UK and Antibiotic Resistance - What Happened?

›
  In 2016 I wrote a series of blogs on the many ways the United Kingdom was leading the fight against antibiotic resistance.    Tamar Gho...
1 comment:
Tuesday, October 2, 2018

Musings on the Introduction of New Antibacterials to the Marketplace

›
I know its been a few weeks since my last blog. A great deal of discussion around antibiotic development and pull incentives is still occ...
Thursday, September 13, 2018

Pathogen Specific Antibacterial Development - Webinar Summary

›
On Tuesday, GARDP sponsored a live webinar on the development of antibacterial drugs for specific pathogens highlighting drugs targeting ...
Tuesday, September 4, 2018

Webinar - Development of Pathogen-Specific Antibacterials

›
I am writing to invite you to our webinar on September 11, 2018. These webinars are part of a series – Clinical Development of Antibacter...
Thursday, August 16, 2018

Investors Hate Antibiotics - With Good Reason!

›
Back in the mid-1990s and even beyond the tech crash of the early 2000s, an antibiotic biotech could frequently raise $50-100 million in ...
Friday, July 27, 2018

You Too, Achaogen?

›
I just learned that  Achaogen  will lay off 80 people in their research and development areas to save money. Achaogen earned its first ...
Saturday, July 21, 2018

Everyone Hates the Pharmaceutical Industry!

›
I think people have good cause to hate the pharmaceutical industry. Their unreasonable prices for specialty drugs (especially in the US), t...